Early and sustained improvements in patient-reported outcomes with tralokinumab in combination with topical corticosteroids as needed in moderate-to-severe atopic dermatitis

被引：0

作者：

Elewski, B. E. ^{[1
]}

Staender, S. ^{[2
,3
]}

Zirwas, M. ^{[4
]}

Silvestre, J. F. ^{[5
]}

Kalia, S. ^{[6
,7
,8
]}

Gutermuth, J. ^{[9
,10
]}

Mark, T. ^{[11
]}

Tindberg, A. M. ^{[11
]}

Silverberg, J. I. ^{[12
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany

[3] Univ Hosp Munster, Interdisciplinary Competence Ctr Chron Pruritus K, Munster, Germany

[4] Prob Med Res, Columbus, OH USA

[5] Hosp Gen Univ Alicante, Dermatol Dept, Alicante, Spain

[6] Univ British Columbia, Dept Dermatol & Skin Sci, Vancouver, BC, Canada

[7] Vancouver Coastal Hlth, Vancouver, BC, Canada

[8] BC Childrens Hosp Res Inst, Vancouver, BC, Canada

[9] Univ Ziekenhuis Brussel, Dept Dermatol, Brussels, Belgium

[10] Vrije Univ Brussel, Brussels, Belgium

[11] LEO Pharma AS, Ballerup, Denmark

[12] George Washington Univ, Sch Med & Hlth Sci, Depat Dermatol, Washington, DC 20052 USA

来源：

BRITISH JOURNAL OF DERMATOLOGY | 2021年 / 184卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

385

引用

页码：E83 / E84

页数：2

共 50 条

[21] Dupilumab elicits rapid and sustained improvements in itch in adults with moderate-to-severe atopic dermatitis [J].

Silverberg, J. I. ;

Eckert, L. ;

Yosipovitch, G. ;

Kim, B. ;

Simpson, E. L. ;

Rossi, A. B. ;

Ardeleanu, M. ;

Chen, Z. ;

Kaur, M. ;

Gadkari, A. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) :S105-S105

[22] Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes [J].

Silverberg, Jonathan I. ;

Thyssen, Jacob P. ;

Simpson, Eric L. ;

Yosipovitch, Gil ;

Staender, Sonja ;

Valdez, Hernan ;

Rojo, Ricardo ;

Biswas, Pinaki ;

Myers, Daniela E. ;

Feeney, Claire ;

DiBonaventura, Marco .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (04) :541-554

[23] Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes [J].

Jonathan I. Silverberg ;

Jacob P. Thyssen ;

Eric L. Simpson ;

Gil Yosipovitch ;

Sonja Ständer ;

Hernan Valdez ;

Ricardo Rojo ;

Pinaki Biswas ;

Daniela E. Myers ;

Claire Feeney ;

Marco DiBonaventura .

American Journal of Clinical Dermatology, 2021, 22 :541-554

[24] Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis [J].

Thyssen, Jacob P. ;

Bieber, Thomas ;

Kleyn, C. Elise ;

Nosbaum, Audrey ;

Grond, Susanne ;

Petto, Helmut ;

Riedl, Elisabeth ;

Wollenberg, Andreas .

JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)

[25] Rocatinlimab demonstrates improvements in patient-reported outcomes in adult patients with moderate-severe atopic dermatitis in a Phase 2 trial [J].

Simpson, Eric ;

Williams, Angela ;

Kirin, Kyowa ;

Chong, Camilla ;

Kirin, Kyowa ;

Esfandiari, Ehsanollah ;

Kirin, Kyowa .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) :AB83-AB83

[26] Patient-reported outcomes from the JADE COMPARE randomized phase 3 study of abrocitinib in adults with moderate-to-severe atopic dermatitis [J].

Thyssen, J. P. ;

Yosipovitch, G. ;

Paul, C. ;

Kwatra, S. G. ;

Chu, C. Y. ;

DiBonaventura, M. ;

Feeney, C. ;

Zhang, F. ;

Myers, D. ;

Rojo, R. ;

Valdez, H. .

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (03) :434-443

[27] DUPILUMAB TREATMENT NORMALIZES INTRAEPIDERMAL NERVE FIBER DENSITY IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS AND IMPROVES PATIENT-REPORTED OUTCOMES [J].

Staender, Sonja ;

Agelopoulos, Konstantin ;

Nattkemper, Leigh ;

Bagel, Jerry ;

Praestgaard, Amy ;

Bologna, Gabriel ;

Mack, Madison ;

Zahn, Joseph ;

Zhang, Annie ;

Yosipovitch, Gil .

ACTA DERMATO-VENEREOLOGICA, 2023, 103 :40-41

[28] Effect of abrocitinib vs dupilumab and placebo on patient-reported outcomes (PROs) in moderate-to-severe atopic dermatitis (AD) in JADE COMPARE [J].

Yosipovitch, Gil ;

Thyssen, Jacob P. ;

Paul, Carle ;

Kwatra, Shawn G. ;

Chu, Chia-Yu ;

Rojo, Ricardo ;

Valdez, Hernan ;

Feeney, Claire ;

Zhang, Fan ;

Myers, Daniela E. ;

DiBonaventura, Marco .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) :AB133-AB133

[29] BUDGET IMPACT ANALYSIS OF TRALOKINUMAB IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS IN THE UK [J].

Chalmers, K. ;

Sawyer, L. ;

Sohrt, A. ;

Robinson, S. ;

Ryttig, L. ;

Rinciog, C. .

VALUE IN HEALTH, 2022, 25 (12) :S124-S124

[30] Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient-Reported Outcomes [J].

Jonathan I. Silverberg ;

Jacob P. Thyssen ;

Eric L. Simpson ;

Gil Yosipovitch ;

Sonja Ständer ;

Hernan Valdez ;

Ricardo Rojo ;

Pinaki Biswas ;

Daniela E. Myers ;

Claire Feeney ;

Marco DiBonaventura .

American Journal of Clinical Dermatology, 2021, 22 :739-739

← 1 2 3 4 5 →